Article info

Download PDFPDF

Extended report
Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial

Authors

  1. Correspondence to Dr Robert Zimmer, ImmuPharma, 5 rue du Rhône, Mulhouse 68000, France; robert.zimmer{at}immupharma.com
View Full Text

Citation

Zimmer R, Scherbarth HR, Rillo OL, et al
Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial

Publication history

  • Accepted October 23, 2012
  • First published November 21, 2012.
Online issue publication 
October 03, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.